Dishman Carbogen Amcis Ltd
Premium PartnerIs this your company? Claim this profile
Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Company Overview
About
Dishman Carbogen Amcis Ltd is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:India
Founded:2015
Employees:2,099
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
North America
Europe
International Regulatory
EU GMP Certificates
2
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval X0RLQ2
Health Canada · #APR-0SXZQCV4 · 2020-09-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-WN3PV38W
Issued: 2020-09-03
Expires: 2025-11-23
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-AZ8FU97W
Issued: 2020-01-06
Expires: 2025-03-16
WHO GMP
World Health Organization
Cert #: CERT-GK7LBEPW
Issued: 2020-03-26
Expires: 2025-04-22
Loading CDMO intelligence...
Key facts about Dishman Carbogen Amcis Ltd
- Dishman Carbogen Amcis Ltd is headquartered in India.
- Dishman Carbogen Amcis Ltd was founded in 2015.
- Dishman Carbogen Amcis Ltd has 2,099 employees.
- Dishman Carbogen Amcis Ltd's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Dishman Carbogen Amcis Ltd
Directory pages this company appears in, each with the full list of matching manufacturers.